UT Southwestern University Hospital - Zale Lipshy — Dallas, Texas

UT Southwestern University Hospital - Zale Lipshy is a clinical research site located in Dallas, Texas, United States 75390.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

UT Southwestern University Hospital - Zale Lipshy has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Non-small Cell Lung Cancer, Lung Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer, Eastern Cooperative Oncology Group.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UT Southwestern University Hospital - Zale Lipshy?

UT Southwestern University Hospital - Zale Lipshy has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UT Southwestern University Hospital - Zale Lipshy conducted?

UT Southwestern University Hospital - Zale Lipshy has 7 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Non-small Cell Lung Cancer, Lung Cancer.

Is UT Southwestern University Hospital - Zale Lipshy accredited by Crixeo Health?

Yes — UT Southwestern University Hospital - Zale Lipshy holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UT Southwestern University Hospital - Zale Lipshy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.